Clinical Trials Logo

Sentinel Lymph Node Biopsy clinical trials

View clinical trials related to Sentinel Lymph Node Biopsy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06212440 Recruiting - Breast Neoplasm Clinical Trials

Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy

Start date: May 4, 2021
Phase: N/A
Study type: Interventional

This clinical trial aimed to confirm the effectiveness of sentinel lymph node surgery by determining the lymph node identification rate using multimodal sentinel lymph node marker methods in patients with advanced breast cancer undergoing neoadjuvant chemotherapy (NAC).

NCT ID: NCT06120439 Recruiting - Breast Cancer Clinical Trials

Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The aim of this randomized controlled trial (RCT) is to assess the Quality of Recovery (QoR) in Breast-conserving Surgery (BCS) with Sentinel Lymph Node Biopsy (SLNB) using Pectoral Nerves (PECS) Block and General Anesthesia (GA). The primary objectives are as follows: First, to determine if the PECS group exhibits better QoR; Second, to investigate if the PECS group experiences less postoperative pain and complications; Third, to examine if the PECS group demonstrates more stable hemodynamics.

NCT ID: NCT05512468 Recruiting - Breast Cancer Clinical Trials

Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

The primary aim of this prospective, multicentre study is to determine whether the involved node can be marked using black carbon dye and successfully identified at the time of surgery. The secondary aims are to determine the concordance between the tattooed node and sentinel node, migration of black dye into other nodes, and false-negative rate of tattooed node (in patients undergoing ALND after NACT).

NCT ID: NCT04403867 Recruiting - Cervical Cancer Clinical Trials

The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.

ITCMicroUtCa
Start date: January 2, 2020
Phase:
Study type: Observational

The role of small-volume lymph node disease (ITC and micro metastases) among patients with endometrial or cervical cancer submitted to sentinel node (SLN) procedure is not clearly defined. This study was designed to create a dataset of patients with lymph nodal disease. Data on type and volume of lymph nodal disease, therapeutic choices and oncological outcomes (DFS, OS, recurrence rate) will be collected and analyzed. This will allow to define the groups of patients who may need or for whom it can be avoided any adjuvant treatment on the basis of lymph node status.

NCT ID: NCT03937414 Recruiting - Clinical trials for Sentinel Lymph Node Biopsy

Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer Patients

Start date: February 1, 2010
Phase: N/A
Study type: Interventional

One-step Nucleic Acid Ampliļ¬cation assay (the OSNA assay) (Sysmex, Kobe, Japan) was an objective molecular technique that combines node tissue homogenization and subsequent reverse-transcription loop-mediated isothermal ampliļ¬cation of CK-19 mRNA in a single quick step. In the study, the performance of the OSNA assay was compared with the present standard histological evaluation, and a comparative analysis of OSNA assay with Touch Imprint Cytology (TIC) was also been made.

NCT ID: NCT03680833 Recruiting - Clinical trials for Sentinel Lymph Node Biopsy

Sentinel Node Detection in Cervical Cancer

SLNcxca
Start date: June 15, 2014
Phase: N/A
Study type: Interventional

Evaluation of sensitivity of Sentinel lymph nodes for detecting nodal metastases in cervical cancer

NCT ID: NCT03199560 Recruiting - Breast Cancer Clinical Trials

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

Start date: June 22, 2017
Phase: Phase 4
Study type: Interventional

A randomized controlled double-blinded study comparing the intraoperative injection of lymphatic mapping agents Tc 99m tilmanocept to Tc 99m filtered sulfur colloid in breast cancer patients undergoing breast conservation and sentinel lymph node biopsy

NCT ID: NCT01564264 Recruiting - Uterine Neoplasms Clinical Trials

Sentinel Node Biopsy in Endometrial Cancer

Start date: November 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if there is a difference between the lymphatic drainage of the cervix and corpus of the uterus after injecting a radiocolloid in the cervix and blue dye in the corpus of the uterus and to investigate the identification rate of sentinel nodes using this technique in patients with cancer of the uterus.

NCT ID: NCT00654342 Recruiting - Colon Cancer Clinical Trials

Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer

Start date: October 2007
Phase: N/A
Study type: Interventional

The technique of sentinel lymph node mapping in patients with colon cancer varies among reports, and the optimal method remain to be established. The purpose of this study was to determine the optimal injection technique for sentinel lymph node mapping for colon cancer.